BAL转录组可识别具有预后意义的IPF内型
BACKGROUND: Given the plethora of pathophysiologic mechanisms described in idiopathic pulmonary fibrosis (IPF), we hypothesize that the mechanisms driving fibrosis in IPF may be different from one patient to another.…
要点
- 基于BAL转录组的IPF内型分型可行,可反映不同病理生理机制。
- 免疫/上皮富集内型校正后生存更差,端粒/线粒体功能障碍内型呈更差趋势。
- 内型相关转录因子及通路为内型定制治疗提供潜在靶点。
核心结论
- 基于基因表达的IPF内型分型可行,可提示临床演变。
- 免疫内型对生存的影响在三个独立验证队列中得到验证。
研究设计与样本
- 使用公共BAL样本基因表达数据集(GSE70867)对IPF和对照样本进行分析。
- 采用DDR Tree降维算法对IPF样本聚类,并行基因集富集分析、临床变量与预后关联分析及基序富集分析。
- 在三个独立公共IPF血液样本基因表达数据集中验证发现。
主要发现
- 生存更差簇富集上皮及固有和适应性免疫信号,另一簇显示端粒和线粒体功能障碍、蛋白稳态丧失及肌成纤维细胞信号增加。
- 两种内型的存在及免疫内型对生存的影响在三个独立验证队列中得到验证。
- 研究识别出调控内型特异性生存相关基因表达的转录因子。
临床怎么用
- BAL转录组内型分型有望辅助判断IPF患者临床演变与预后。
- 内型特异性通路和生存相关转录因子为内型定制治疗提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given the plethora of pathophysiologic mechanisms described in idiopathic pulmonary fibrosis (IPF), we hypothesize that the mechanisms driving fibrosis in IPF may be different from one patient to another. RESEARCH QUESTION: Do IPF endotypes exist and are they associated with outcome? STUDY DESIGN AND METHODS: Using a publicly available gene expression dataset retrieved from BAL samples of patients with IPF and control participants (GSE70867), we clustered IPF samples based on a dimension reduction algorithm specifically designed for -omics data, called DDR Tree. After clustering, gene set enrichment analysis was performed for functional annotation, associations with clinical variables and prognosis were investigated, and differences in transcriptional regulation were determined using motif enrichment analysis. The findings were validated in three independent publicly available gene expression datasets retrieved from IPF blood samples. RESULTS: One hundred seventy-six IPF samples from three centers were clustered in six IPF clusters, with distinct functional enrichment. Although clinical characteristics did not differ between the clusters, one cluster conferred worse sex-age-physiology score-corrected survival, whereas another showed a numeric trend toward worse survival (P = .08). The first was enriched for increased epithelial and innate and adaptive immunity signatures, whereas the other showed important telomere and mitochondrial dysfunction, loss of proteostasis, and increased myofibroblast signatures. The existence of these two endotypes, including the impact on survival of the immune endotype, was validated in three independent validation cohorts. Finally, we identified transcription factors regulating the expression of endotype-specific survival-associated genes. INTERPRETATION: Gene expression-based endotyping in IPF is feasible and can inform clinical evolution. As endotype-specific pathways and survival-associated transcription factors are identified, endotyping may open up the possibility of endotype-tailored therapy.
引用
- De Sadeleer LJ, Verleden SE, Schupp JC, et al. BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact. Chest. 2022. PMID: 35063449. doi:10.1016/j.chest.2021.12.668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。